9.03.07: Canadian Biotechnology Report
3 analysts and top management from 5 firms examine the Canadian Biotechnology segment in this 30 page report from The Wall Street Transcript. Order this Report

  1. Canadian Healthcare & Biotechnology: Shameze Rampertab, Jennings Capital Inc.

  2. Canadian Biotechnology Companies: Claude Camire, Paradigm Capital Inc.

  3. Canadian Healthcare & Biotechnology: Joseph Walewicz, CIBC World Markets

  4. CEO Interviews (average 2,500 words): Top management from 5 sector firms examine the outlook for their firm and sector. Firms interviewed include: ARIUS Research Inc., Biotech Holdings Ltd., Medical Ventures Corp., MedMira Inc., and Nexia Biotechnologies Ltd.

    Topics covered: Tax-supporting mechanisms - M&A interest - Lack of IPOs - Attracting capital - Critical mass - Product development stages - Acquisition of technologies and drugs - Emerging biotechnology - Service companies - Diagnostics - Specialty pharmaceuticals - Increasingly competitive environment - Promotion of new companies with new technologies - Introduction of new drugs - US partnerships - Commercial sales in the US - Laterstage clinical development

    Companies covered: Theratechnologies (TH:TSX), Protox Therapeutics (PRX:TSX), Nventa Biopharmaceuticals (NVN:TSX), MedcomSoft (MSF:TSX), ProMetic Life Sciences (PLI:TSX), IntelGenx (IGXT), Biovail (BVF), AEterna Zentaris (AEZS), Axcan (AXCA), and Keryx Biopharmaceuticals (KERX).
    ORDER THIS REPORT NOW! CLICK HERE

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher

HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE